QX002N injection group:QX002N injection

2 trials

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Conditions

Active ankylosing spondylitisankylosing spondylitis

Phase 2

A multicenter, randomized, double-blind, placebo-controlled phase II clinical study for evaluating the efficacy and safety of QX002N injection in patients with active ankylosing spondylitis

RecruitingChiCTR2100053338

Peking Union Medical College Hospital, Chinese Academy of Medical SciencesActive ankylosing spondylitis

Start: 2021-12-04Updated: 2022-10-17

A long-term, open-label study to evaluate the safety and efficacy of QX002N injection in patients with active ankylosing spondylitis

Active, not recruitingChiCTR2200065495

Peking Union Medical College Hospital, Chinese Academy of Medical Sciencesankylosing spondylitis

Start: 2022-11-18Updated: 2023-05-15